Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA–induced dyskinesia

Abstract

L-DOPA–induced dyskinesia, the rate-limiting side effect in the therapy of Parkinson's disease, is mediated by activation of mammalian target of rapamycin (mTOR) signaling in the striatum. We found that Ras homolog enriched in striatum (Rhes), a striatal-specific protein, binds to and activates mTOR. Moreover, Rhes−/− mice showed reduced striatal mTOR signaling and diminished dyskinesia, but maintained motor improvement on L-DOPA treatment, suggesting a therapeutic benefit for Rhes-binding drugs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Rhes binds and activates mTOR.
Figure 2: Effect of Rhes deletion on mTOR striatal signaling and dyskinesia in unilaterally 6-OHDA–lesioned mice.

Similar content being viewed by others

References

  1. Santini, E., Heiman, M., Greengard, P., Valjent, E. & Fisone, G. Sci. Signal. 2, 36 (2009).

    Article  Google Scholar 

  2. Subramaniam, S., Sixt, M.K., Barrow, R. & Snyder, S.H. Science 324, 1327–1330 (2009).

    Article  CAS  Google Scholar 

  3. Seredenina, T., Gokce, O. & Luthi-Carter, R. PLoS ONE 6, e22231 (2011).

    Article  CAS  Google Scholar 

  4. Subramaniam, S. et al. J. Biol. Chem. 285, 20428–20432 (2010).

    Article  CAS  Google Scholar 

  5. Long, X., Lin, Y., Ortiz-Vega, S., Yonezawa, K. & Avruch, J. Curr. Biol. 15, 702–713 (2005).

    Article  CAS  Google Scholar 

  6. Vargiu, P. et al. Oncogene 23, 559–568 (2004).

    Article  CAS  Google Scholar 

  7. Errico, F. et al. Mol. Cell. Neurosci. 37, 335–345 (2008).

    Article  CAS  Google Scholar 

  8. Santini, E. et al. J. Neurosci. 27, 6995–7005 (2007).

    Article  CAS  Google Scholar 

  9. Quintero, G.C., Spano, D., Lahoste, G.J. & Harrison, L.M. Neuroreport 19, 1563–1566 (2008).

    Article  CAS  Google Scholar 

  10. Sancak, Y. et al. Science 320, 1496–1501 (2008).

    Article  CAS  Google Scholar 

  11. Malagelada, C., Jin, Z.H., Jackson-Lewis, V., Przedborski, S. & Greene, L.A. J. Neurosci. 30, 1166–1175 (2010).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank R. Romano, D. Vitucci, V. Marsili, P. Scherer and S. Korde for valuable technical assistance, and R. DiLauro (University of Naples) for providing the Rhes−/− mice. This work was supported by United States Public Health Service grant MH18501 (S.H.S.) and a grant of the Cure for Huntington's Disease Initiative (S.H.S.).

Author information

Authors and Affiliations

Authors

Contributions

S.S. initiated the project and conducted the mTOR binding and activation experiments, which were further characterized by R.G.M. A.U. initiated the dyskinesia and mTOR experiments in mice. S.S. and S.H.S. further conceived and designed the experiments. F.N. and F.E. conducted the L-DOPA and behavioral experiments, under the direction of A.U. R.B. generated the Rhes constructs. S.K. performed the in vitro mTOR activity assay. R.T. and N.S. contributed to the mTOR activity and binding experiments. S.H.S. wrote the manuscript with input from R.G.M., S.S. and A.U.

Corresponding author

Correspondence to Solomon H Snyder.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Text and Figures

Supplementary Text and Supplementary Figures 1–10 (PDF 1320 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Subramaniam, S., Napolitano, F., Mealer, R. et al. Rhes, a striatal-enriched small G protein, mediates mTOR signaling and L-DOPA–induced dyskinesia. Nat Neurosci 15, 191–193 (2012). https://doi.org/10.1038/nn.2994

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nn.2994

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing